United States securities and exchange commission logo





                          February 9, 2021

       Feng Zhou
       Chief Executive Officer
       China SXT Pharmaceuticals, Inc.
       178 Taidong Rd North, Taizhou
       Jiangsu, China

                                                        Re: China SXT
Pharmaceuticals, Inc.
                                                            Registration
Statement on Form F-3
                                                            Filed February 2,
2021
                                                            File No. 333-252664

       Dear Mr. Zhou:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Deanna
Virginio at 202-551-4530 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Joan Wu, Esq.